Literature DB >> 26584692

Intralesional Candida Antigen Immunotherapy for the Treatment of Recalcitrant and Multiple Warts in Children.

Fania Z Muñoz Garza1, Esther Roé Crespo1, Mauricio Torres Pradilla1, Paula Aguilera Peirò1, Susana Baltà Cruz1, María Eugenia Hernández Ruiz1, Eulàlia Baselga Torres1.   

Abstract

BACKGROUND: Intralesional injection of Candida antigen appears to be an effective alternative for the treatment of warts. AIM: To determine the efficacy and safety of this treatment.
METHODS: We retrospectively reviewed records of all children who received intralesional injection of Candida antigen at our center from January 2008 to July 2013.
RESULTS: From a total of 220 patients, 156 (70.9%) had a complete response, 37 (16.8%) had a partial response, and 27 (12.2%) had no improvement. An average of 2.73 treatments was needed. Forty-seven of the patients with more than one wart (21.3%) also noted at least partial resolution of untreated warts at distant sites. Twenty-seven of the 47 patients (57.4%) had complete resolution. All treated patients experienced some discomfort at the time of the injection, but no serious side effects were reported. DISCUSSION: We report our results using this approach in a large group of children.
CONCLUSION: Intralesional injection of Candida antigen is an effective and safe therapy for children with multiple and recalcitrant cutaneous warts.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26584692     DOI: 10.1111/pde.12667

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  5 in total

1.  Management of Difficult-to-Treat Warts: Traditional and New Approaches.

Authors:  Peter C Friedman
Journal:  Am J Clin Dermatol       Date:  2021-01-11       Impact factor: 7.403

2.  A Comparative Study of Intralesional Vitamin D3, Measles Mumps Rubella Vaccine, and Tuberculin Purified Protein Derivative in the Treatment of Recalcitrant Warts: An Approach to Solve a Therapeutic Conundrum.

Authors:  Srishti Jain; Yogesh S Marfatia
Journal:  J Clin Aesthet Dermatol       Date:  2021-11

3.  The efficacy and safety of intralesional Candida vaccine versus topical diphencyproprobenone in immunotherapy of verruca vulgaris: A randomized comparative study.

Authors:  Mohamed H M El-Komy; Shahenda Gamal Shamma; Nermeen Ibrahim Bedair
Journal:  Arch Dermatol Res       Date:  2022-10-17       Impact factor: 3.033

4.  Uveitis Following Treatment of Verruca Vulgaris with Intralesional Candida Antigen.

Authors:  Nicholas J Crowley; John C Hagan; Jonathan A Dyer; Tyler F Brundige
Journal:  Mo Med       Date:  2017 Sep-Oct

Review 5.  Evolving role of immunotherapy in the treatment of refractory warts.

Authors:  Devinder M Thappa; Minu J Chiramel
Journal:  Indian Dermatol Online J       Date:  2016 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.